However, nurses should assess patients for more serious adverse effects, such as: Pancreatitis Gallbladder disease Renal impairment due to dehydration Risk of thyroid C-cell tumors (in animal studies) Caution is warranted in patients with: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 Severe gastrointestinal disease In addition, GLP-1 medications are not intended for use in individuals with type 1 diabetes or as first-line treatment for obesity without lifestyle intervention
March 9, 2026: Woman Sues Eli Lilly, Accuses Mounjaros Manufacturer of Failing to Warn About Severe Gastric Side Effects A woman has filed a lawsuit in New Jersey against Mounjaros manufacturer, Eli Lilly, and several other companies after she experienced severe complications
Although metagenomic analysis using Next-Generation Sequencing (NGS) is useful for estimating the overall view of the gut microbiota, it is less sensitive than qPCR at the species or strain level 50
Proof of Prior Efforts: Many BCBS plans will demand documented evidence that youve tried and failed to lose weight through other methods, such as diet and exercise programs, for a specific period (often six months)